Microbiology & Infectious Diseases

Fecal microbiota transplantation (FMT), an emerging therapy for conditions like irritable bowel syndrome (IBS), continues to raise questions about the safety of transferring certain microorganisms, especially the intestinal parasite Blastocystis spp.

Pseudomonas aeruginosa, a leading cause of microbial keratitis, continues to challenge clinicians with rising antimicrobial resistance.

Clostridioides difficile infection (CDI) remains a pressing challenge in older adults, particularly those with comorbidities, leading to significant mortality and healthcare costs.

Each flu season, influenza quietly inflicts a heavy toll on U.S. adults aged 18 to 64, with hospitalizations and deaths mounting, especially among older adults and those with chronic conditions.

In the United States, statin initiation for atherosclerotic cardiovascular disease (ASCVD) prevention remains strikingly low, even among individuals with a clear clinical indication, according to a new prospective observational study.

New data from the U.S.-based HERO Study shed light on an important question for hepatitis C virus (HCV) management: How effective is retreatment among people who inject drugs (PWID)?

A new systematic review and meta-analysis sheds light on the growing role of antimicrobial stewardship programs (ASPs) in improving clinical outcomes for hospitalized adults with community-acquired pneumonia (CAP), a condition that remains a leading cause of hospitalization and antibiotic use in the United States.

In the clinical landscape of biliary tract infections, accurately predicting which patients are at risk of severe bloodstream infections (BSIs) can be lifesaving.